Imunon, Inc.
IMNN
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -1.13M | 0.00 | 1.67M | 359.30K | 674.10K |
| Gross Profit | 1.13M | 0.00 | -1.67M | -359.30K | -674.10K |
| SG&A Expenses | 7.76M | 7.49M | 7.99M | 8.25M | 8.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.27M | 19.13M | 20.95M | 19.90M | 20.36M |
| Operating Income | -18.27M | -19.13M | -20.95M | -19.90M | -20.36M |
| Income Before Tax | -17.79M | -18.62M | -20.73M | -19.36M | -20.13M |
| Income Tax Expenses | -- | -- | -1.28M | -1.28M | -1.28M |
| Earnings from Continuing Operations | -17.79 | -18.62 | -19.45 | -18.08 | -18.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.79M | -18.62M | -19.45M | -18.08M | -18.85M |
| EBIT | -18.27M | -19.13M | -20.95M | -19.90M | -20.36M |
| EBITDA | -18.03M | -18.89M | -20.68M | -19.62M | -20.09M |
| EPS Basic | -1.41 | -1.65 | -1.89 | -1.92 | -2.02 |
| Normalized Basic EPS | -0.88 | -1.03 | -1.27 | -1.29 | -1.33 |
| EPS Diluted | -1.41 | -1.65 | -1.89 | -1.92 | -2.02 |
| Normalized Diluted EPS | -0.88 | -1.03 | -1.27 | -1.29 | -1.33 |
| Average Basic Shares Outstanding | 52.93M | 47.77M | 42.65M | 37.58M | 37.32M |
| Average Diluted Shares Outstanding | 52.93M | 47.77M | 42.65M | 37.58M | 37.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |